Professional of the Year for 2010 in Cancer Drug Research: Tricia J. Vos, Ph.D.
![]() | Tricia J. Vos, Ph.D. |
Industry | Pharmaceutical |
Title | Senior Scientist II |
Expertise | Oncology, Drug Discovery, Medicinal Chemistry |
Current Organization | Millennium: The Takeda Oncology Company |
Type of Organization | R&D |
Major Product | Cancer drugs |
Area of Distribution | National/International |
University/Degree | B.A., Franklin & Marshall College; Ph.D., University of Minnesota |
Born | July 5, 1972 |
Honors & Awards | Phi Beta Kappa |
Published Works | Publications include-"Antitumor Activity of MLN8054, an Orally Small-Molecule Inhibitor of Aurora A Kinase", Manfredi MC, Ecsedy JA, Meetze KA, Balani SK, Burenkova O, Chen W, Galvin KM, Hoar KM, Huck JJ, LeRoy RJ, Ray ET, Sells TB, Stringer B, Stroud SG, Vos TJ, Weatherhead GS, Wysong DR, Zhang M, Bolen JD, Claiborne CF, Proc. Natl. Acad. Sci. (USA) 2007, 104(10), 4106-4111 and "Identification and Structure-Activity Relationships of a New Series of Melanocortin-4 Receptor Antagonists", Vos TJ, Balani S, Blackburn C, Chau R, Danca MD, Drabic SV, Farrer CA, Patane MA, Stroud SG, Yowe, DL, Claiborne CF, Bioorg. Med. Chem. Lett. 2006, 16, 2302-2305; Patents and Patent Applications include- "Preparation of Pyrazoline Derivatives with Raf Kinase Inhibitory Activity", Adams RS, Duffey M, Gould AE, Greenspan PD, Kulkarni BA, Vos TJ, WO 08/079277; Presentations include- "Small Molecule MC4 Receptor Antagonists", Vos TJ, IBC's Hit to Lead Success Stories Conference, San Diego, CA, 2005 |
Affiliations | ACS |
Full biographical and contact details are available to logged in members only. If you are a member please log in using the form in the header to see more data. If you are not already member you may Click Here to Register for consideration. |